Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- HIV Prevention
- Sponsor
- Hilary L Surratt, PhD
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Number of Participants Initiating PrEP
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The overarching goal of this study is to adapt and feasibility test an evidence-based strengths-based case management (SBCM) intervention for pre-exposure prophylaxis (PrEP) initiation, and examine preliminary efficacy of the intervention comparators (SBCM-PrEP) and (Centers for Disease Control (CDC)-PrEP). Within this context, the Specific Aims are to: 1) Assess client, provider, organization, and structural-level facilitators and barriers to integration of a PrEP focused SBCM (SBCM-PrEP) intervention into routine syringe service program (SSP) practice; 2) Adapt an evidence-based SBCM protocol to provide PrEP intervention services for people who inject drugs (PWID) in SSP sites; and, 3) Examine feasibility, acceptability and preliminary efficacy of the adapted SBCM-PrEP. 80 participants will be randomized into: CDC-PrEP (an in-use PrEP intervention based on CDC guidelines) or SBCM-PrEP.
Investigators
Hilary L Surratt, PhD
Associate Professor
University of Kentucky
Eligibility Criteria
Inclusion Criteria
- •Age 18 years or older;
- •HIV-negative status;
- •Past month drug injection;
- •Client of SSP in targeted sites
Exclusion Criteria
- •HIV-positive status
Outcomes
Primary Outcomes
Number of Participants Initiating PrEP
Time Frame: 6 months post-baseline
Documented PrEP initiation, measured by dispensed PrEP prescription.
Secondary Outcomes
- Level of Intervention Engagement Assessed by Session Checklist(8 weeks post-baseline)
- Level of Intervention Satisfaction Assessed by the IAQ(8 weeks post-baseline)